Maximum Single Dose of Phenobarbital in Adults
For adults, the maximum single intravenous dose of phenobarbital is 20 mg/kg (maximum 1000 mg) for status epilepticus, administered over 10-15 minutes, with the infusion rate not exceeding 60 mg/min. 1
Intravenous Dosing
Status Epilepticus (Primary Indication)
- Loading dose: 15-20 mg/kg IV over 10-15 minutes 2, 1
- Maximum single dose: 1000 mg 2
- Infusion rate: Must not exceed 60 mg/min 1
- Repeat dosing: Can administer additional 5-10 mg/kg at 10-minute intervals if seizures persist 3
- Maximum total dose: Up to 36 mg/kg has been used in refractory cases 4
Acute Convulsions (Non-Status)
Critical Safety Considerations for IV Administration
Respiratory depression is the primary concern, particularly when combined with benzodiazepines or other sedatives. 2 You must:
- Have airway management equipment immediately available
- Monitor oxygen saturation continuously
- Be prepared to provide mechanical ventilation
- Maintain blood pressure, respiration, and cardiac function monitoring throughout administration 1
Vascular access matters critically: Use large veins only—avoid dorsum of hand or wrist. 1 Inadvertent intraarterial injection can cause gangrene requiring amputation. 1 Always aspirate before injecting to confirm venous placement.
Oral Dosing
Acute Sedation/Hypnosis
Preoperative Sedation
- IM only: 100-200 mg administered 60-90 minutes before surgery 1
Special Populations & Clinical Context
Alcohol Withdrawal
Research demonstrates effective loading with 260 mg IV initially, followed by 130 mg every 30 minutes to achieve light sedation, with mean total loading doses of approximately 600 mg. 5 This produces serum levels rising approximately 1.65 mcg/mL per mg/kg administered. 5
Refractory Status Epilepticus
In intensive care settings treating superrefractory status epilepticus, loading doses up to 36 mg/kg have been used, though this requires ICU-level monitoring and ventilatory support. 4 The typical approach involves initial 10-20 mg/kg loading, with additional 5-10 mg/kg boluses as needed. 3
Palliative Sedation
Recent data shows loading doses of 50-200 mg subcutaneously (most commonly 200 mg), followed by continuous infusions of 400-1200 mg/24 hours (most commonly 800 mg/24 hours), with maximum doses reaching 1800 mg/24 hours. 6 Subcutaneous administration appears safe in this specific context despite traditional contraindications.
Common Pitfalls to Avoid
Infusion rate violations: Exceeding 60 mg/min IV dramatically increases hypotension and cardiac dysrhythmia risk 1
Inadequate monitoring: The combination of phenobarbital with benzodiazepines (commonly given first for status epilepticus) substantially increases apnea risk 2
Subcutaneous administration: Generally contraindicated due to tissue irritation, except in palliative care settings where recent evidence supports its use 1, 6
Tolerance misunderstanding: Chronic users tolerate higher doses but NOT higher serum concentrations before respiratory failure—they remain at risk for lethal toxicity at similar blood levels 7
Premature extracorporeal removal: In overdose situations with chronic users, rapid reduction of serum levels via dialysis can precipitate severe withdrawal seizures 7
Pharmacokinetic Considerations
Oral bioavailability is excellent at 95-96%, making oral and IV dosing nearly equivalent on a mg-per-mg basis for non-emergent situations. 8, 9 The elimination half-life averages 5-6 days in adults, meaning steady-state takes approximately 3 weeks to achieve. 8
Ideal body weight (IBW) is the appropriate dosing weight, not actual body weight, as demonstrated in critically ill patients where IBW significantly impacts volume of distribution and clearance. 9